Werner loses again on issue of deaf driver, but dollar amounts are a lot lower
The financial stakes in the case brought by the Equal Employment Opportunity Commission under the provisions of the Americans with Disabilities Act are now about $335,000, a far cry from a jury's decision in 2023 to award deaf truck driver Victor Robinson about 107 times that figure.
The unanimous decision last week from an Eighth Circuit Court of Appeals three-judge panel fully affirmed all the September 2023 decisions from both a jury trial in the U.S. District Court for Nebraska and later decisions handed down from the bench over post-trial motions.
The affirmation includes a reduction in the original punitive damages awarded by the jury. That reduction came after the court ruled that EEOC awards are capped at $300,000.
The EEOC was the plaintiff in the case on behalf of Victor Robinson.The defendants along with Werner (NASDAQ: WERN) included Drivers Management LLC, which is Werner's training subsidiary.
Werner made several points on appeal, all of which were rejected by the appellate court.
A recap of the case in the recent appellate court decision noted that Robinson had a 'medical variance' from the Federal Motor Carrier Safety Administration (FMCSA). That waiver is needed for a deaf driver to obtain a CDL. It was obtained in 2015.
With the variance in hand, Robinson enrolled in Roadmaster, the driving school owned by Werner. His training involved not just a regular trainer but also an interpreter for the deaf, 'who communicated with Robinson from the backseat of the vehicle throughout the process,' according to the court's recap of the case's history.
In September 2016, Robinson completed the training and received his CDL. But soon after, according to the recap of the case by the appellate court, Werner Vice President of Safety and Compliance Jamie Hamm told him on a call, 'I'm sorry, we can't hire you because of your deafness.'
The call took place, according to the court, after Robinson had been told he had been preapproved for employment by recruiter Erin Marsh in an email. After calling Marsh–using a relay service for the phone call–the two talked about, according to the court, ''the job, the orientation, providing interpreting services,' and other general matters.'
The district court's decision in January 2024 to award back pay to Robinson of about $35,000 lists several driving jobs Robinson had after not being hired at Werner, none of which lasted very long; only one, with Stan Koch Trucking, reached 12 months. Other jobs on his record included with J.B. Hunt (NASDAQ: JBHT) and U.S. Xpress, now part of Knight Swift (NYSE: KNX).
The roughly $335,000 award is a combination of the punitive damages, capped at $300,000, and the backpay.
In a May 2024 series of decisions on post-trial motions in the case, the district court summed up the basis for the jury's decision against Werner. 'The jury determined that Robinson was qualified to perform the job to which he applied, he could have safely performed the essential functions of the job with a reasonable accommodation, and Werner's refusal to hire Robinson was not based on business necessity,' District Court Judge John Gerrard wrote.
There were multiple issues raised by Werner in its appeal over events in the trial. They included the question of 'causation' and whether Robinson's dismissal was because of his deafness; whether Robinson's overall driving record (which included several accidents) could be introduced to the jury; Werner objections to the admission of emails sent between Werner executives on the decision-making to deny Robinson employment; whether hiring a deaf driver would provide 'undue hardship' for Werner; and whether the FMCSA waiver meant Werner could not deny Robinson employment on the basis of his deafness.
Ultimately, the appellate court did not side with Werner on any of the points made in its appeal.
An email to Werner seeking comment had not been responded to by publication time.
More articles by John Kingston
At a conference of mostly green investors, AlFleet pushes marriage of AI and trucking
Another broker liability case knocks at Supreme Court door, this one involving C.H. Robinson
XPO rating cut by S&P, agency cites continuing weak freight market
The post Werner loses again on issue of deaf driver, but dollar amounts are a lot lower appeared first on FreightWaves.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Nvidia and Broadcom: Here's How These Top AI Stocks Are Doing 1 Year After Their Stock Splits
Key Points These leading AI players saw their shares skyrocket in the year prior to their stock splits, with levels reaching beyond $1,000. Nvidia and Broadcom both have reported soaring demand for their products. 10 stocks we like better than Nvidia › Stock splits were a big thing last year, with many major companies across industries launching such operations. Two of the most exciting were in the area of artificial intelligence (AI). Nvidia (NASDAQ: NVDA), the world's No. 1 AI chip designer, and Broadcom (NASDAQ: AVGO), a networking giant, completed stock splits in June and July 2024, respectively. What is a stock split, and why do companies go this route? These operations enable a company to bring down a soaring stock price to more reasonable levels, making the stock more accessible to a broader range of investors. Nvidia and Broadcom even said they decided on splits to make it easier for employees and investors to get in on their shares, which had surged more than 200% and about 100%, respectively, in 2023. Stock splits don't change the total market value of the company or anything fundamental, though. They simply involve offering more shares to current holders according to the ratio of the split. So, for example, in a 10-for-1 stock split, if you originally held one share, you would hold 10 shares post-split -- but the total value of your holding would remain the same. Because of this, a stock split alone isn't a reason to buy or sell a stock. Still, it's interesting to see how stock split players have performed a year after these operations, so let's take a look at both Nvidia and Broadcom a year after their splits. Nvidia Nvidia completed its 10-for-1 stock split on June 7 of last year, with shares trading at the split-adjusted price as of June 10. This brought the shares down from about $1,200 to $120. Since that time, Nvidia stock has experienced ups and downs, but it's delivered a gain of more than 40%. As mentioned, this operation isn't the reason investors have flocked to Nvidia over the past year (though a lower price per share may have made it easier for some to get in on the growth story). What has driven Nvidia's share price performance is the ongoing high demand for its graphics processing units (GPUs), or AI chips, and related products and services. What also helped this AI leader was its strong execution of a big launch: Nvidia released its Blackwell architecture and chip this past winter to demand that CEO Jensen Huang called "insane." The company generated $11 billion in revenue from Blackwell in its very first quarter of commercialization and maintained a gross margin above 70%, ensuring high profitability on sales. Although investors worried about potential headwinds, such as import tariffs or a decrease in AI spending, these concerns have eased. Trade talks have spurred optimism that tariffs may not be as hefty as initially expected, and companies have reiterated their AI investment plans. All of this helped boost Nvidia's shares in recent weeks, even pushing the company to a $4 trillion market cap, making it the first company ever to reach this level. Broadcom Broadcom executed its stock split on July 12, and the stock began trading on July 15 at the new price. Like Nvidia, the company decided on a 10-for-1 split to bring its share price down -- in this case, from about $1,700 to $170. Broadcom stock has also climbed in the double digits since the operation, rising more than 65%. And like Nvidia, Broadcom saw its shares take off thanks to demand from AI customers. This company is a networking leader, making thousands of products used in a variety of locations -- from your smartphone to major data centers. But in recent times, demand from big cloud service providers to support their AI development has helped revenue skyrocket. In the most recent quarter, AI revenue surged 77% to $4.1 billion, and the company says it expects this momentum to continue in the current quarter and through the next fiscal year. This is amid demand for both connectivity products and Broadcom's accelerated processing units (XPUs), a type of processor for specific AI tasks. The company says its networking expertise and wide range of products -- from switches and routers to network interface cards (NICs), which connect computers to networks -- have been key growth drivers as cloud service providers ramp up their AI platforms. Broadcom stock followed a similar path to Nvidia, declining in April of this year due to general tariff concerns, but it has also rebounded and is on the rise today. The stock even closed at a record high just a few days ago. Could the post-split success continue? Both Nvidia and Broadcom have completed successful post-split years, scoring double-digit gains. Nvidia is slightly less expensive from a valuation standpoint than it was a year ago, but Broadcom's valuation has advanced. Still, these AI players remain reasonably priced, considering their earnings track record and long-term prospects in this growth market. It's impossible, of course, to guarantee what these stocks will do next, but the current environment supports the idea of more gains ahead. Even more importantly, Nvidia and Broadcom are well positioned to win in the AI market over the long run. Should you buy stock in Nvidia right now? Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!* Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025 Adria Cimino has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nvidia. The Motley Fool recommends Broadcom. The Motley Fool has a disclosure policy. Nvidia and Broadcom: Here's How These Top AI Stocks Are Doing 1 Year After Their Stock Splits was originally published by The Motley Fool
Yahoo
35 minutes ago
- Yahoo
You Have $1,000 to Invest. Should You Buy GOOG or GOOGL?
Key Points Alphabet offers investors exposure to powerful tech megatrends like artificial intelligence (AI), cybersecurity, and autonomous transportation -- all under one roof. Alphabet trades under two ticker symbols, but they both represent the same underlying business. Unless voting rights are important to you, either ticker is a great way to invest in this "Magnificent Seven" stock. 10 stocks we like better than Alphabet › The "Magnificent Seven" is a popular tag for the most dominant, high-performing tech companies on the planet. Alphabet (NASDAQ: GOOGL), (NASDAQ: GOOG), Amazon, Apple, Meta Platforms, Microsoft, Nvidia, and Tesla have delivered market-crushing returns over the past decade, in large part because their businesses are on the forefront of the most disruptive technology macrotrends in modern history. While all seven companies are juggernauts in their own right, one Magnificent Seven stock stands out due to its dominant core business, exposure to multiple megatrends, and attractive valuation relative to its cohorts. That stock is Alphabet. An unconventional company There's something else that makes Alphabet different. Unlike the other members of the Magnificent Seven, Alphabet trades under two tickers: GOOG and GOOGL. Why would Alphabet do that? A little history will provide some helpful context. Larry Page and Sergey Brin founded Google (Alphabet's predecessor) in 1998. When Google filed its IPO paperwork in 2004, Page declared in a letter to prospective shareholders: "Google is not a conventional company. We do not intend to become one." In that same letter, Page fretted that becoming a public company could undermine the independence and creative spirit that had been critical to Google's success. He also made it clear that the company would not "shy away from high-risk, high-reward projects" just to hit some arbitrary quarterly financial target. To ensure that Page, Brin, and the rest of the executive team would retain "control over the company's decisions and fate," Google implemented a dual-class stock structure. It's all about insider control Common stock represents partial ownership in a company, and it usually comes with the right to vote on issues such as executive compensation, board members, and mergers and acquisitions. When Google debuted as a publicly traded company in August 2004, it used the dual class structure to concentrate 99% of the voting power in the hands of its founders, executives, and board members. Here's how: Each share of Class A common stock (available to regular investors) came with one vote. Each share of Class B common stock (held by founders and insiders) came with 10 votes. At the time, Page acknowledged that this was an unconventional move for a tech company, although it wasn't uncommon for other types of businesses. Perhaps the most well-known example is Berkshire Hathaway. However, in the years since Google's 2004 IPO, a number of tech companies have adopted dual class structures to maintain insider control, including Meta Platforms, Palantir, and Roblox. . This is where it gets a little confusing In April 2014, Google added another layer of complexity to its share structure by way of a 2-for-1 stock split. On April 2, 2014, Google's shareholders received one share of newly issued Class C stock for every share of Class A stock that they already owned. Starting on April 3, 2014, two classes of Google stock were available to the public: Class A shares (GOOGL): One vote per share Class C shares (GOOG): No voting power The important thing to note is the Class C shares don't come with voting rights. That was the whole point of the 2014 stock split. By issuing nonvoting Class C shares, Google could fund acquisitions and offer stock-based compensation and incentives without diluting executives' voting power. To recap, this is the share structure that exists today: Class A shares (GOOGL): One vote per share Class B shares (held by insiders): 10 votes per share Class C shares (GOOG): No voting power Should you buy GOOG or GOOGL? Today, Google the search engine is just one piece of Alphabet, the umbrella company formed in 2015. What makes Alphabet such a compelling investment is that it's not just a search-engine provider. Owning Alphabet is a bit like owning an ETF with exposure to some of the biggest themes in tech -- from cloud computing and AI to autonomous vehicles, cybersecurity, and streaming. And as I alluded to earlier, Alphabet trades at a discount to its Magnificent Seven cohorts based on its forward price-to-earnings (P/E) ratio: But there's still one question left to answer: Is GOOG or GOOGL the better investment? Because GOOGL comes with voting rights, you'd think it would trade at a premium to its Class C sibling, GOOG. But interestingly enough, GOOG has outperformed GOOGL since April 3, 2014, ever-so-slightly: As of July 16, GOOG was priced at $183.77, just a hair above GOOGL at $182.97. So based on the recent price action, you could look at it this way: GOOGL gives you the same exposure to Alphabet's basket of businesses, but at a slightly lower price, with the added benefit of voting power. In reality, most regular investors can't purchase enough shares to have any meaningful impact on the company's strategic direction through their votes. And because both tickers represent the same underlying security, there likely will never be any wide variation in price between the two. So unless you care deeply about voting rights, either ticker is a great way to invest in this Magnificent Seven standout. Should you buy stock in Alphabet right now? Before you buy stock in Alphabet, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Alphabet wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!* Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025 John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. Josh Cable has positions in Alphabet, Amazon, Berkshire Hathaway, Microsoft, Nvidia, and Palantir Technologies. The Motley Fool has positions in and recommends Alphabet, Amazon, Apple, Berkshire Hathaway, Meta Platforms, Microsoft, Nvidia, Palantir Technologies, Roblox, and Tesla. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. You Have $1,000 to Invest. Should You Buy GOOG or GOOGL? was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
35 minutes ago
- Yahoo
A Once-in-a-Lifetime Opportunity: This Blue Chip Healthcare Stock Down 50% Could Double Your Money
Key Points Novo Nordisk's recent financial results and clinical progress haven't impressed Wall Street. However, the company can right the ship through innovation in its core specialty and elsewhere. The stock looks attractively valued at current levels and could beat the market over the next six years. 10 stocks we like better than Novo Nordisk › Investors looking to strike while the iron is hot can buy beaten-down stocks that appear to have excellent chances of bouncing back. And that describes shares of Novo Nordisk (NYSE: NVO) very well. The pharmaceutical leader is down by 52% over the trailing-12-month period as of July 17, but initiating a position now could double investors' money in six years or so. Here's why this stock is a screaming buy at its current levels. Novo Nordisk's recent challenges Novo Nordisk focuses on developing diabetes treatments, an area where it has been a leader for many decades. As of February, it held a 33.3% market share for diabetes drugs. This sort of long-term dominance doesn't happen by accident. The company has consistently attracted top talent in the pharmaceutical industry, which, combined with its extensive experience in diabetes, has enabled it to break new ground repeatedly. Why, then, have the company's shares dropped by 52% over the past year? Because Novo Nordisk failed to impress the market with its financial results and clinical progress. The developments that led to the drugmaker's share plunge would have been excellent for almost any other pharmaceutical company, but investors held it to a higher standard given its rich valuation metrics. For instance, the company reported phase 3 results for CagriSema, an investigational weight management medicine, that proved it's more effective than its famous semaglutide (Wegovy), reducing patients' weight by an average of 22.7% in 68 weeks. However, management was looking for a 25% figure in the study. Very few anti-obesity therapies in development have achieved results comparable to CagriSema, but that was not enough to please investors. The good news: Novo Nordisk's pipeline in diabetes and the fast-growing area of weight management remains robust. The company has several promising candidates in development, including Amycretin, for which it recently initiated late-stage studies. And management has significantly expanded its pipeline through acquisitions. Even with mounting competition, the company should continue to be one of the leaders in its core areas of focus. It's been developing medicines in other fields as well, including various rare diseases (such as the blood disorders beta thalassemia and sickle cell disease), neurological disorders (including Alzheimer's and Parkinson's), and others. Making progress in diabetes and obesity while diversifying its lineup should work wonders for Novo Nordisk down the line. The price is right Net sales in the first quarter grew by 19% year over year to 78.1 billion Danish krone ($12.1 billion). The company's net profit was up 14% year over year to $4.5 billion. These would be excellent results for most similarly sized drugmakers, yet Wall Street remains unimpressed. In my view, that has created a wonderful opportunity to buy shares on the dip. The company's forward price-to-earnings ratio (P/E) has declined significantly over the past year and now stands at 16.9, barely above the healthcare industry's 16.2 and lower than the S&P 500's 22.3. But given Novo Nordisk's still excellent position in its core markets of diabetes and obesity treatments -- the latter of which should grow rapidly in the coming years -- and the company's better-than-average revenue and earnings growth, its stock is arguably worth a steeper premium. In fact, the forward P/E is about as low as it has been in over two years. At current levels, shares look like a steal. Here is how things could evolve for the company in the next six years. First, it could make significant clinical and regulatory progress and launch at least one -- if not several -- blockbuster weight loss or diabetes medications. Second, the company should continue recording strong results, with revenue and earnings moving in the right direction. Lastly, it looks likely to continue increasing its dividend, which it has done significantly over the past half-decade. The stock needs a compound annual growth rate of 12.2% to double in the next six years. Novo Nordisk can pull it off, especially for those who opt to reinvest the dividend. Should you buy stock in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!* Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025 Prosper Junior Bakiny has positions in Novo Nordisk. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. A Once-in-a-Lifetime Opportunity: This Blue Chip Healthcare Stock Down 50% Could Double Your Money was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data